𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association of genetic polymorphism of low-density lipoprotein receptor with chronic viral hepatitis C infection in Han Chinese

✍ Scribed by Han Li; Zhengwen Liu; Qunying Han; Yan Li; Jinghong Chen


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
125 KB
Volume
78
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

To study the association between the Ava II polymorphism at the low‐density lipoprotein receptor (LDL‐R) gene exon 13 locus and chronic hepatitis C virus (HCV) infection in the Han Chinese, 84 chronic HCV‐infected patients without anti‐viral treatment, and 72 healthy blood donors were studied. Polymerase chain reaction combined with restriction fragment length polymorphism (PCR‐RFLP) was used to detect the Ava II polymorphism at the LDL‐R gene exon 13 locus. The comparisons of genotype distribution and allele frequency between chronic HCV‐infected patients and healthy controls showed statistically significant differences (P = 0.045 and P = 0.036, respectively). Additionally, the minor allele frequency (MAF) C in the healthy controls was higher than that in the chronic HCV‐infected patients group. There was no significant difference (P = 0.130) when the genotype distribution was compared between chronic HCV‐infected patients with HCV viremia and those without HCV viremia. However, the comparisons of allele frequency between the two groups showed a statistically significant difference (P = 0.047), and the MAF C in HCV RNA negative group was significantly higher than that in HCV RNA positive group. There were no significant differences in genotype distribution and allele frequency of the Ava II restriction site at the LDL‐R gene exon 13 locus between patients with chronic HCV infection and those with HCV‐associated cirrhosis as well as between patients with normal serum alanine aminotransferase (ALT) and those with abnormal ALT levels. These results suggest that the Han Chinese have Ava II polymorphism at the LDL‐R gene exon 13 locus. The Ava II polymorphism at the LDL‐R gene exon 13 locus showed a statistically significant difference between chronic HCV‐infected patients and healthy controls, indicating a significant contribution of the Ava II polymorphism in susceptibility to HCV infection in these patients. The MAF C in HCV RNA negative group was higher than that in HCV RNA positive group, suggesting that the Ava II polymorphism might also be associated with viremia in patients with HCV infection. J. Med. Virol. 78:1289–1295, 2006. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Association of NKG2D genetic polymorphis
✍ Juan Ma; Xinhui Guo; Xiaopan Wu; Junhong Li; Xilin Zhu; Zhuo Li; Jingyun Li; Lip 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract Natural killer (NK) cells are important antiviral effectors of innate immunity because of their contribution to virus elimination. NK cell‐mediated immunological reaction to hepatitis B virus (HBV) infection depends on a fine balance between inhibitory and activating receptors. The aim

Genetic variability of hepatitis C virus
✍ I. Vuillermoz; E. Khattab; E. Sablon; I. Ottevaere; D. Durantel; C. Vieux; C. Tr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

## Abstract Little is known about hepatitis C virus (HCV) breakthrough during antiviral therapy, although it would help in understanding HCV resistance to current antiviral treatments. To analyse the implication of virological factors and the vigour of humoral immune responses in this phenomenon, w

Lack of association of trinucleotide rep
✍ Haeyong Chung Ba; Carol T. Roberts; Steven Greenberg; G. William Rebeck; Richard 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 2 views

Inheritance of the apolipoprotein E E 4 allele is a risk factor for Alzheimer's disease (AD). A recent report studying Japanese patients suggested that a polymorphism of a trinucleotide repeat in the 5' untranslated region of an apolipoprotein E receptor, the very-low-density lipoprotein receptor, i